The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
Scientists create a new 3D lung cancer model to better reveal the drivers of cancer, and in doing so, find a new gene that may be a possible drug target.
A team led by Howard Chang has contributed key technology to enable new experimental cancer therapy that uses CRISPR to edit immune cells.
Researchers zeroed in on the genes driving ground squirrel hibernation — and their insights could be helpful for understanding human health.
Scientists develop a technology to find "jumping genes," a type of genetic element that may contribute to antibiotic resistance.
In his quest to cure his daughter’s ultra-rare disease, Matt Wilsey might also be changing the way drugs are made, Stanford Business magazine reports.
A Stanford biomedical data scientist discusses how computational modeling of big data could help improve personalized chemotherapy selection in the future.
Through genetic tests and databases of symptoms, doctors in a network of clinical centers help families determine what is affecting their children's health.
Scientists have used CRISPR-Cas9 screens to reveal more about how the bacteria behind Legionnaire's disease infects humans.
Mammalian cells use a label to distinguish self from non-self circular RNA molecules. Foreign molecules can trigger anti-cancer immune responses.
Scientists have used CRISPR-Cas9 gene editing technology to decipher the genes critical to the success of a type of cancer drug, antibody-drug conjugates.
Scientists at Stanford use a gene therapy technique, called RNA silencing, to treat a heart condition called restrictive cardiomyopathy in mice.
A Stanford scientist and his son harness RNA sequencing to discover the genomic mutation behind the uncommon California poppy.
Stanford scientists have found 16 new genetic variants linked to a greater risk for autism, a finding that could help identify biomarkers for the disorder.
Researchers at Stanford have created an algorithm that predicts how likely CRISPR gene editing will yield off-target mutations.
This In the Spotlight features Helio Costa, a geneticist who has developed an assay currently being used to help cancer patients.